Keyword: Repatha

Novartis headquarters

6. Novartis/The Medicines Company

Novartis has agreed to buy The Medicines Company for $85 per share in a $9.7 billion cash transaction, a price that it might have overpaid. Though it’s buying the entire firm, the deal is really just about one drug: cardiovascular contender inclisiran.